420
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Incidence and Predictors of Chronic Kidney Disease among Diabetes Mellitus Patients: A Retrospective Follow-Up Study at a Tertiary Health-Care Setting of Ethiopia

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 4381-4390 | Published online: 28 Oct 2021

References

  • ADA. Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. Diabetes Care . 2018;41(Supplement 1):S13–S27. doi:10.2337/dc18-S002 29222373
  • Inernational Diabetes federation. Diabetes Atlas . 9th ed. 2019.
  • Rao Kondapally Seshasai S , Kaptoge S , Thompson A , et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med . 2011;364(9):829–841.21366474
  • Reutens AT . Epidemiology of diabetic kidney disease. Med Clinics . 2013;97(1):1–18.
  • De Cosmo S , Viazzi F , Piscitelli P , et al. Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes. J Hypertens . 2016;34(10):2090–2098. doi:10.1097/HJH.0000000000001045 27457667
  • Gallagher H , Suckling R . Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?. Diabetes Obe Metab . 2016;18(7):641–647. doi:10.1111/dom.12630
  • Eknoyan G , Lameire N , Eckardt K , et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int . 2013;3(1):5–14.
  • Wang H , Naghavi M , Allen C , et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet . 2016;388(10053):1459–1544.27733281
  • Jha V , Garcia-Garcia G , Iseki K , et al. Chronic kidney disease: global dimension and perspectives. Lancet . 2013;382(9888):260–272. doi:10.1016/S0140-6736(13)60687-X 23727169
  • Wagnew F , Eshetie S , Kibret GD , et al. Diabetic nephropathy and hypertension in diabetes patients of sub-Saharan countries: a systematic review and meta-analysis. BMC Res Notes . 2018;11(1):565. doi:10.1186/s13104-018-3670-5 30081966
  • Fiseha T , Kassim M , Yemane T . Prevalence of chronic kidney disease and associated risk factors among diabetic patients in southern Ethiopia. Am J Health Res . 2014;2(4):216–221. doi:10.11648/j.ajhr.20140204.28
  • Damtie S , Biadgo B , Baynes HW , et al. Chronic kidney disease and associated risk factors assessment among diabetes mellitus patients at a Tertiary Hospital, Northwest Ethiopia. Ethiop J Health Sci . 2018;28:6.
  • Go A , Chertow G , Fan D . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. J Vasc Surg . 2005;41(1):177. doi:10.1016/j.jvs.2004.10.020
  • Roglic G . WHO Global report on diabetes: a summary. Int J Noncommun Dis . 2016;1(1):3. doi:10.4103/2468-8827.184853
  • Neuen BL , Chadban SJ , Demaio AR , Johnson DW , Perkovic V . Chronic kidney disease and the global NCDs agenda. BMJ Global Health . 2017;2(2):e000380. doi:10.1136/bmjgh-2017-000380
  • Abraham G . The Challenges of Renal Replacement Therapy in Asia . Nature Publishing Group; 2008.
  • Rajapurkar MM , John GT , Kirpalani AL , et al. What do we know about chronic kidney disease in India: first report of the Indian CKD registry. BMC Nephrol . 2012;13(1):10. doi:10.1186/1471-2369-13-10 22390203
  • Liyanage T , Ninomiya T , Jha V , et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet . 2015;385(9981):1975–1982. doi:10.1016/S0140-6736(14)61601-9 25777665
  • Salinero-Fort MA , San Andrés-Rebollo FJ , de Burgos-Lunar C , et al. Five-year incidence of chronic kidney disease (stage 3-5) and associated risk factors in a Spanish cohort: the MADIABETES study. PLoS One . 2015;10(4):e0122030. doi:10.1371/journal.pone.0122030 25856231
  • Muntner P , Coresh J , Smith JC , Eckfeldt J , Klag MJ . Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int . 2000;58(1):293–301. doi:10.1046/j.1523-1755.2000.00165.x 10886574
  • Bowe B , Xie Y , Xian H , Balasubramanian S , Al-Aly Z . Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression. Kidney Int . 2016;89(4):886–896. doi:10.1016/j.kint.2015.12.034 26924057
  • Geletu AH , Teferra AS , Sisay MM , Teshome DF . Incidence and predictors of chronic kidney diseases among type 2 diabetes mellitus patients at St. Paul’s Hospital, Addis Ababa, Ethiopia. BMC Res Notes . 2018;11(1):532.30064516
  • Luk AOY , So WY , Ma RCW , et al. Metabolic syndrome predicts new onset of chronic kidney disease in 5829 patients with Type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care . 2008;31(12):2357–2361. doi:10.2337/dc08-0971 18835954
  • Wolde HF , Atsedeweyen A , Jember A , et al. Predictors of vascular complications among type 2 diabetes mellitus patients at University of Gondar Referral Hospital: a retrospective follow-up study. BMC Endocr Disord . 2018;18(1):52. doi:10.1186/s12902-018-0280-0 30064436
  • Wilkinson CP , Ferris FL 3rd Klein RE , et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology . 2003;110(9):1677–1682. doi:10.1016/S0161-6420(03)00475-5 13129861
  • WHO. Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee . Vol. 854. Geneva: World Health Organization technical report series; 1995:1–452.
  • WHO. Regional Office for the Western Pacific. Noncommunicable Disease Education Manual for Primary Health Care Professionals and Patients . Manila: WHO Regional Office for the Western Pacific; 2017. Available from: https://apps.who.int/iris/handle/10665/254746. Accessed October 19, 2021.
  • Grundy SM . Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation . 2002;106:3143–3421.12485966
  • Patient Care & Health Information. Tests & procedures: Mayo Foundation for Medical Education and Research ((MFMER); 2019. Available from: https://www.mayoclinic.org/tests-procedures/cholesterol-test/about/pac-20384601. Accessed October 19, 2021.
  • Schoenfeld DA . Sample-size formula for the proportional-hazards regression model. Biometrics . 1983;39(2):499–503. doi:10.2307/2531021 6354290
  • Kim WJ , Kim SS , Bae MJ , et al. High-normal serum uric acid predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus and preserved kidney function. J Diabetes Compl . 2014;28(2):130–134. doi:10.1016/j.jdiacomp.2013.11.006
  • van Blijderveen JC , Straus SM , Zietse R , Stricker BH , Sturkenboom MC , Verhamme KM . A population-based study on the prevalence and incidence of chronic kidney disease in the Netherlands. Int Urol Nephrol . 2014;46(3):583–592. doi:10.1007/s11255-013-0563-3 24072454
  • Koopman RJ , Mainous AG , Diaz VA , Geesey ME . Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000. Ann Fam Med . 2005;3(1):60–63. doi:10.1370/afm.214 15671192
  • Derose SF , Rutkowski MP , Crooks PW , et al. Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system. Am J Kidney Dis . 2013;62(2):236–244. doi:10.1053/j.ajkd.2013.01.019 23499049
  • Grams ME , Rebholz CM , Chen Y , et al. Race, APOL1 risk, and eGFR decline in the general population. J Am Soc Nephrol . 2016;27(9):2842–2850. doi:10.1681/ASN.2015070763 26966015
  • Schimke K , Chubb SA , Davis WA , Davis TM . Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study. Atherosclerosis . 2010;212(1):321–326. doi:10.1016/j.atherosclerosis.2010.05.021 20839379
  • Bentata Y , Haddiya I , Latrech H , Serraj K , Abouqal R . Progression of diabetic nephropathy, risk of end-stage renal disease and mortality in patients with type-1 diabetes. Saudi J Kidney Dis Transplant . 2013;24(2):392. doi:10.4103/1319-2442.109617
  • Retnakaran R , Cull CA , Thorne KI , Adler AI , Holman RR . Risk factors for renal dysfunction in type 2 diabetes: UK Prospective Diabetes Study 74. Diabetes . 2006;55(6):1832–1839. doi:10.2337/db05-1620 16731850
  • Worldometer. Life Expectancy of the World Population, Countries ranked by life expectancy; 2020. Available from: https://www.worldometers.info/demographics/life-expectancy/. Accessed October 19, 2021.
  • Coresh J , Astor BC , Greene T , Eknoyan G , Levey AS . Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis . 2003;41(1):1–12. doi:10.1053/ajkd.2003.50007
  • Hayslett JP , Kashgarian M , Epstein FH . Functional correlates of compensatory renal hypertrophy. J Clin Invest . 1968;47(4):774–782. doi:10.1172/JCI105772 5641618
  • Thomson SC , Vallon V , Blantz RC . Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physio . 2004;286(1):F8–F15. doi:10.1152/ajprenal.00208.2003
  • Lipworth L , Mumma MT , Cavanaugh KL , et al. Incidence and predictors of end stage renal disease among low-income blacks and whites. PLoS One . 2012;7(10):e48407. doi:10.1371/journal.pone.0048407 23110237
  • Silbiger S , Neugarten J . Gender and human chronic renal disease. Gend Med . 2008;5:S3–S10. doi:10.1016/j.genm.2008.03.002 18395681
  • Ferrara A , Karter AJ , Ackerson LM , Liu JY , Selby JV . Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: the Northern California Kaiser Permanente Diabetes Registry. Diabetes Care . 2001;24(7):1144–1150. doi:10.2337/diacare.24.7.1144 11423493
  • Dixon A , Wells CC , Singh S , Babayan R , Maric C . Renoprotective effects of a selective estrogen receptor modulator, raloxifene, in an animal model of diabetic nephropathy. Am J Nephrol . 2007;27(2):120–128. doi:10.1159/000099837 17308373
  • Mankhey RW , Wells CC , Bhatti F , Maric C . 17β-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney. Am J Physiol Regul Int Comp Physiol . 2007;292(2):R769–R77. doi:10.1152/ajpregu.00375.2006
  • Yu MK , Katon W , Young BA . Associations between sex and incident chronic kidney disease in a prospective diabetic cohort. Nephrology . 2015;20(7):451–458. doi:10.1111/nep.12468 25807970
  • Dickson LE , Wagner MC , Sandoval RM , Molitoris BA . The proximal tubule and albuminuria: really! J Am Soc Nephrol . 2014;25(3):443–453.24408874
  • Jefferson J , Shankland S , Pichler R . Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int . 2008;74(1):22–36. doi:10.1038/ki.2008.128 18418356
  • Kuusniemi A-M , Lapatto R , Holmberg C , Karikoski R , Rapola J , Jalanko H . Kidneys with heavy proteinuria show fibrosis, inflammation, and oxidative stress, but no tubular phenotypic change. Kidney Int . 2005;68(1):121–132. doi:10.1111/j.1523-1755.2005.00386.x 15954901
  • Tejera N , Gómez-Garre D , Lázaro A , et al. Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells. Am J Pathol . 2004;164(5):1817–1826. doi:10.1016/S0002-9440(10)63740-6 15111328
  • Nolin AC , Mulhern RM , Panchenko MV , et al. Proteinuria causes dysfunctional autophagy in the proximal tubule. Am J Physiol Renal Physiol . 2016;311(6):F1271–F9. doi:10.1152/ajprenal.00125.2016 27582098
  • Jiang G , Luk AOY , Tam CHT , et al. Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes. Kidney Int . 2019;95(1):178–187. doi:10.1016/j.kint.2018.08.026 30415941
  • Pavkov ME , Knowler WC , Hanson RL , Bennett PH , Nelson RG . Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes. Am J Kidney Dis . 2008;51(5):759–766. doi:10.1053/j.ajkd.2008.01.011 18436086
  • Van Der Velde M , Matsushita K , Coresh J , et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A Collaborative Meta-Analysis of High-Risk Population Cohorts. Kidney Int . 2011;79(12):1341–1352.21307840
  • Gansevoort RT , Matsushita K , van der Velde M , et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes in both general and high-risk populations: a collaborative meta-analysis of general and high-risk population cohorts. Kidney Int . 2011;80(1):93. doi:10.1038/ki.2010.531 21289597
  • He C , Imai M , Song H , Quigg RJ , Tomlinson S . Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9. J Immunol . 2005;174(9):5750–5757. doi:10.4049/jimmunol.174.9.5750 15843577
  • Cravedi P , Remuzzi G . Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease. Br J Clin Pharmacol . 2013;76(4):516–523.23441592
  • Krishnan SM , Ling YH , Huuskes BM , et al. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension. Cardiovasc Res . 2019;115(4):776–787. doi:10.1093/cvr/cvy252 30357309
  • Soto K , Gómez-Garre D , Largo R , et al. Tight blood pressure control decreases apoptosis during renal damage. Kidney Int . 2004;65(3):811–822. doi:10.1111/j.1523-1755.2004.00455.x 14871401
  • Goligorsky MS , Chen J , Brodsky S . Workshop: endothelial cell dysfunction leading to diabetic nephropathy: focus on nitric oxide. Hypertension . 2001;37(2):744–748. doi:10.1161/01.HYP.37.2.744 11230367
  • Link JJ , Rohatgi A , de Lemos JA . HDL cholesterol: physiology, pathophysiology, and management. Curr Probl Cardiol . 2007;32(5):268–314. doi:10.1016/j.cpcardiol.2007.01.004 17481993